(Q28373079)

English

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy (English)

0 references

0 references

1 reference

G W Pogson

1

0 references

L H Kindred

series ordinal

2

0 references

B G Carper

series ordinal

3

0 references

language of work or name

English

0 references

publication date

1 April 1999

0 references

published in

American Journal of Cardiology

0 references

volume

83

0 references

issue

7

0 references

page(s)

1146

0 references

cites work

Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Rhabdomyolysis after taking atorvastatin with gemfibrozil

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Preclinical and clinical pharmacology of cerivastatin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900034-X

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0002-9149(99)00034-X

0 references

PubMed publication ID

10190540

0 references

(Q28373079)

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)